Brandywine Managers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Sell |
4,218
-130
| -3% | -$42.4K | 1.37% | 11 |
|
|
2025
Q1 | $1.17M | Hold |
4,348
| – | – | 1.41% | 11 |
|
|
2024
Q4 | $1.02M | Hold |
4,348
| – | – | 1.08% | 13 |
|
|
2024
Q3 | $1.2M | Hold |
4,348
| – | – | 1.29% | 12 |
|
|
2024
Q2 | $1.06M | Hold |
4,348
| – | – | 1.12% | 15 |
|
|
2024
Q1 | $650K | Hold |
4,348
| – | – | 0.64% | 23 |
|
|
2023
Q4 | $832K | Sell |
4,348
-260
| -6% | -$49.8K | 0.91% | 16 |
|
|
2023
Q3 | $816K | Hold |
4,608
| – | – | 1.38% | 14 |
|
|
2023
Q2 | $875K | Hold |
4,608
| – | – | 0.58% | 22 |
|
|
2023
Q1 | $923K | Hold |
4,608
| – | – | 0.66% | 19 |
|
|
2022
Q4 | $1.1M | Hold |
4,608
| – | – | 3.83% | 5 |
|
|
2022
Q3 | $922K | Hold |
4,608
| – | – | 3.03% | 8 |
|
|
2022
Q2 | $672K | Hold |
4,608
| – | – | 1.65% | 16 |
|
|
2022
Q1 | $752K | Hold |
4,608
| – | – | 1.3% | 22 |
|
|
2021
Q4 | $781K | Hold |
4,608
| – | – | 0.89% | 26 |
|
|
2021
Q3 | $870K | Hold |
4,608
| – | – | 0.91% | 25 |
|
|
2021
Q2 | $781K | Hold |
4,608
| – | – | 0.89% | 25 |
|
|
2021
Q1 | $651K | Buy |
4,608
+1,708
| +59% | +$241K | 0.87% | 28 |
|
|
2020
Q4 | $377K | Hold |
2,900
| – | – | 0.52% | 33 |
|
|
2020
Q3 | $422K | Hold |
2,900
| – | – | 0.8% | 26 |
|
|
2020
Q2 | $430K | Hold |
2,900
| – | – | 1.77% | 21 |
|
|
2020
Q1 | $316K | Hold |
2,900
| – | – | 0.11% | 20 |
|
|
2019
Q4 | $334K | Sell |
2,900
-200
| -6% | -$23K | 0.1% | 35 |
|
|
2019
Q3 | $249K | Hold |
3,100
| – | – | 0.08% | 37 |
|
|
2019
Q2 | $225K | Sell |
3,100
-900
| -23% | -$65.3K | 0.08% | 44 |
|
|
2019
Q1 | $374K | Sell |
4,000
-200
| -5% | -$18.7K | 0.15% | 34 |
|
|
2018
Q4 | $306K | Buy |
+4,200
| New | +$306K | 0.14% | 28 |
|